0.09 CNY
57.00 M CNY
2.31 B CNY
235.84 M
About SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT
Sector
CEO
Bin Feng
Headquarters
Shanghai
Website
Founded
1983
ISIN
CNE000000453
FIGI
BBG000BFXNS6
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. engages in the research, development, production and sale of pharmaceuticals. Its products include anti-tumor series, cardiovascular series, cerebrovascular series, cough and cold series, magic doll pediatric series, antifungal series, and tonic products. The company was founded in 1983 and is headquartered in Shanghai, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 600613 is 7.71 CNY — it has increased by 3.55% in the past 24 hours. Watch SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT stocks are traded under the ticker 600613.
600613 stock has risen by 1.07% compared to the previous week, the month change is a 1.88% rise, over the last year SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT has showed a −5.28% decrease.
600613 reached its all-time high on Jun 15, 2015 with the price of 28.57 CNY, and its all-time low was 3.46 CNY and was reached on Oct 29, 2008. View more price dynamics on 600613 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
600613 stock is 3.61% volatile and has beta coefficient of 1.36. Track SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT stock price on the chart and check out the list of the most volatile stocks — is SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT there?
Today SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT has the market capitalization of 3.91 B, it has decreased by −2.59% over the last week.
Yes, you can track SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT financials in yearly and quarterly reports right on TradingView.
600613 net income for the last quarter is 21.52 M CNY, while the quarter before that showed 13.89 M CNY of net income which accounts for 54.88% change. Track more SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT financial stats to get the full picture.
Yes, 600613 dividends are paid annually. The last dividend per share was 0.10 CNY. As of today, Dividend Yield (TTM)% is 1.37%. Tracking SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT dividends might help you take more informed decisions.
SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT dividend yield was 1.31% in 2023, and payout ratio reached 93.72%. The year before the numbers were 1.22% and 110.01% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 12, 2024, the company has 1.43 K employees. See our rating of the largest employees — is SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT on this list?
Like other stocks, 600613 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT stock shows the buy signal. See more of SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.